期刊文献+

论药品不良反应信息通报制度的目的与作用 被引量:4

Purpose and Effect of the Information Notification System of Adverse Drug Reactions
原文传递
导出
摘要 目的:利用《药品不良反应(ADR)信息通报》,进一步发挥药物警戒与干预的作用,有效避免或减少ADR。方法:收集国家ADR监测中心自2001年11月~2009年5月发布的共22期《ADR信息通报》,运用Excel软件进行数据分类统计,探讨《ADR信息通报》制度的目的与作用。结果:《ADR信息通报》的定期公布,使ADR病例报告数量显著提高,但同时也存在政府监管部门与临床用药单位信息反馈滞缓,部分药品反复通报但ADR仍重复发生与蔓延等现象。被通报药品中,中药ADR居多,占25%以上;重复通报的14个药品中,中药高达50%。结论:需进一步采取多种形式加强ADR的宣传与培训,使医务人员有效利用《ADR信息通报》,确保公众用药安全。 OBJECTIVE: To bring the effect of the pharmacovigilance and intervention into full play through "ADR (adverse drug reactions) Notifications" in order to effectively avoid or reduce the incidence of ADR. METHODS: The data collected from a total of 22"ADR Notifications" (periodical No. 22) issued from Nov. 2001 to May 2009 by national ADR Monitoring Center were analyzed statistically by using Excel software, and the purpose and effect of the ADR notification system were discussed. RESULTS: Through periodic publication of "ADR Notifications", the number of the informed ADR cases increased markedly. The delayed information feedback of government supervision department and clinical medication department were also noted, and some drugs were notified repeatedly yet the ADR induced by these drugs occurred repeatedly and extensively. Most of reported ADR cases were induced by traditional Chinese medicines, by which more than 25% of the ADRs were induced, and more than half of the 14 kinds of repeatedly notified drugs were traditional Chinese medicines. CONCLUSION: Numerous methods should be taken to strengthen ADR monitoring and training of medical staff to effectively utilize ADR notifications to ensure medication safety of the public.
出处 《中国药房》 CAS CSCD 北大核心 2009年第29期2241-2244,共4页 China Pharmacy
关键词 药品不良反应 药物警戒 信息通报 目的 作用 Adverse drug reactions (ADR) Pharmacovigilance Notification Purpose Effect
  • 相关文献

参考文献3

二级参考文献4

共引文献32

同被引文献30

  • 1吴文炎,吴红革.流感疫苗不良反应文献分析[J].中国全科医学,2009,12(2):129-130. 被引量:12
  • 2袁晔,白海蓬,宋立刚,王琦.药品不良反应公众认知度调查分析[J].中国药物警戒,2006,3(5):280-282. 被引量:14
  • 3卫生部,国家食品药品监督管理局.药品不良反应报告和监测管理办法[z].局令第7号.2004-03-04.
  • 4国家食品药品监督管理局.甲型H1N1流感病毒裂解疫苗说明书(暂定)[z].2009-9-25.
  • 5张新平,李少丽葛物政策学[M].北京:科学出版社,2003.
  • 6覃正碧,向继洲,卢祖洵,周杰明,李元启,郭卫春.我国药品不良反应报告和监测及其实施探讨[J].中国药房,2007,18(29):2297-2301. 被引量:20
  • 7陈易新,田春华.从药品不良反应信息通报品种看药品风险管理(一)[J].中国药物警戒,2007,4(5):257-260. 被引量:14
  • 8EHRENPREIS ED, DEEPAK P, SIFUENTES H, et al. The me- toclopramide black box warning for tardive dyskinesia: effect on clinical practice, adverse event reporting, and prescription drug lawsuits [ J ]. Am J Gastroenterol, 2013, 108 ( 6 ) : 866 - 872.
  • 9KALES HC, ZIVIN K, KIM HM, et al. Trends in antipsychotic use in dementia 1999-2007[J]. Arch Gen Psychiatry, 2011, 68 (2) : 190-197.
  • 10SINGH RR, NAYAK R, Impact of FDA black box warning on psychotropic drug use in noninstitutionalized elderly patients diag- nosed with dementia: a retrospective study [ J]. J Pharm Pract, 2015, [ Epub ahead of print].

引证文献4

二级引证文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部